Urologie pro praxi 1/2023
Management of the metastatic renal cancer
Metastatic renal cancer is serious disease with serious prognosis. The management covers surgery od primary tumor, eventually on metastasis. Lymphadenectomy has no therapeutical impact; it is useful for staging only. Monoclonal antibody, tyrosinkinase inhibitors, mammalian targets of rapamycin (mTOR) and cytokines can be used for oncological management. The complex therapy needs multidisciplinary cooperation and well-informed patient.
Keywords: renal cancer, metastasis, therapy.
